Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Sorlí L[au]:

Search results

Items: 1 to 50 of 62

1.

Systemic pharmacokinetics and safety of high doses of nebulized colistimethate sodium in critically ill patients with hospital-acquired and ventilator-associated pneumonia.

Benítez-Cano A, de Antonio-Cuscó M, Luque S, Sorlí L, Carazo J, Ramos I, Bermejo S, Campillo N, Horcajada JP, Samsó E, Grau S.

J Antimicrob Chemother. 2019 Sep 8. pii: dkz356. doi: 10.1093/jac/dkz356. [Epub ahead of print]

PMID:
31495877
2.

Linezolid versus glycopeptides in the treatment of glycopeptide-susceptible Enterococcus faecium bacteremia: A propensity-score matched comparative study.

Echeverria-Esnal D, Sorli L, Prim N, Conde-Estévez D, Mateu-De Antonio J, Martin-Ontiyuelo C, Horcajada JP, Grau S.

Int J Antimicrob Agents. 2019 Aug 30. pii: S0924-8579(19)30236-5. doi: 10.1016/j.ijantimicag.2019.08.018. [Epub ahead of print]

PMID:
31476435
3.

Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections.

Horcajada JP, Montero M, Oliver A, Sorlí L, Luque S, Gómez-Zorrilla S, Benito N, Grau S.

Clin Microbiol Rev. 2019 Aug 28;32(4). pii: e00031-19. doi: 10.1128/CMR.00031-19. Print 2019 Sep 18. Review.

PMID:
31462403
4.

Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical.

Sorlí L, Luque S, Li J, Campillo N, Danés M, Montero M, Segura C, Grau S, Horcajada JP.

J Infect. 2019 Sep;79(3):253-261. doi: 10.1016/j.jinf.2019.06.011. Epub 2019 Jun 29.

PMID:
31265867
5.

Linezolid dosing in patients with liver cirrhosis: Standard dosing risks toxicity.

Luque S, Muñoz-Bermudez R, Echeverría-Esnal D, Sorli L, Campillo N, Martínez-Casanova J, González-Colominas E, Álvarez-Lerma F, Horcajada JP, Grau S, Roberts JA.

Ther Drug Monit. 2019 Jun 26. doi: 10.1097/FTD.0000000000000665. [Epub ahead of print]

PMID:
31259884
6.

Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.

Montero MM, Domene Ochoa S, López-Causapé C, VanScoy B, Luque S, Sorlí L, Campillo N, Padilla E, Prim N, Segura C, Pomar V, Rivera A, Grau S, Ambrose PG, Oliver A, Horcajada JP.

J Glob Antimicrob Resist. 2019 May 30;18:37-44. doi: 10.1016/j.jgar.2019.04.012. [Epub ahead of print]

PMID:
31154007
7.

The Different Microbial Etiology of Prosthetic Joint Infections according to Route of Acquisition and Time after Prosthesis Implantation, Including the Role of Multidrug-Resistant Organisms.

Benito N, Mur I, Ribera A, Soriano A, Rodríguez-Pardo D, Sorlí L, Cobo J, Fernández-Sampedro M, Del Toro MD, Guío L, Praena J, Bahamonde A, Riera M, Esteban J, Baraia-Etxaburu JM, Martínez-Alvarez J, Jover-Sáenz A, Dueñas C, Ramos A, Sobrino B, Euba G, Morata L, Pigrau C, Horcajada JP, Coll P, Crusi X, Ariza J; REIPI (Spanish Network for Research in Infectious Disease) Group for the Study of Prosthetic Joint Infections / GEIO (Group for the Study of Osteoarticular Infections), SEIMC (Spanish Society of Infectious Diseases and Clinical Microbiolo.

J Clin Med. 2019 May 13;8(5). pii: E673. doi: 10.3390/jcm8050673.

8.

Population Pharmacokinetics of Anidulafungin in Critically Ill Patients.

Luque S, Hope W, Campillo N, Muñoz-Bermúdez R, Sorli L, Barceló-Vidal J, González-Colominas E, Alvarez-Lerma F, Masclans JR, Montero M, Horcajada JP, Grau S.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00378-19. doi: 10.1128/AAC.00378-19. Print 2019 Jul.

PMID:
31061150
9.

Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients?

Sorli L, Luque S, Li J, Rodríguez E, Campillo N, Fernandez X, Soldado J, Domingo I, Montero M, Grau S, Horcajada JP.

Molecules. 2019 Feb 1;24(3). pii: E530. doi: 10.3390/molecules24030530.

10.

Serum albumin is a strong predictor of sepsis outcome in elderly patients.

Arnau-Barrés I, Güerri-Fernández R, Luque S, Sorli L, Vázquez O, Miralles R.

Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):743-746. doi: 10.1007/s10096-019-03478-2. Epub 2019 Jan 24.

PMID:
30680575
11.

High-dose benznidazole in a 62-year-old Bolivian kidney transplant recipient with Chagas central nervous system involvement.

Montero M, Mir M, Sulleiro E, Avalos Esquivel JL, García López E, Molina-Morant D, López Montesinos I, Sorlí L, Veliz Espinosa G, Mounteis Oliva E, Crespo M, Monge I, Horcajada JP, Grau S, Pascual J.

Int J Infect Dis. 2019 Jan;78:103-106. doi: 10.1016/j.ijid.2018.10.014. Epub 2018 Oct 25.

12.

Candida periprosthetic joint infection: A rare and difficult-to-treat infection.

Escolà-Vergé L, Rodríguez-Pardo D, Lora-Tamayo J, Morata L, Murillo O, Vilchez H, Sorli L, Carrión LG, Barbero JM, Palomino-Nicás J, Bahamonde A, Jover-Sáenz A, Benito N, Escudero R, Sampedro MF, Vidal RP, Gómez L, Corona PS, Almirante B, Ariza J, Pigrau C; Study Group on Osteoarticular Infections of the Spanish Society of Clinical Microbiology and Infectious Diseases (GEIO-SEIMC), and the Spanish Network for Research in Infectious Pathology (REIPI).

J Infect. 2018 Aug;77(2):151-157. doi: 10.1016/j.jinf.2018.03.012. Epub 2018 May 8.

PMID:
29746950
13.

Results of cement spacer sonication in the second stage of two-stage treatment of shoulder arthroplasty infection.

Torrens C, Santana F, Puig L, Sorli L, Alier A.

J Orthop Surg Res. 2018 Mar 20;13(1):58. doi: 10.1186/s13018-018-0763-8.

14.

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis.

Martínez-Casanova J, Carballo N, Luque S, Sorli L, Grau S.

Infect Drug Resist. 2018 Mar 5;11:317-321. doi: 10.2147/IDR.S154457. eCollection 2018.

15.

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.

Esteve-Palau E, Grau S, Herrera S, Sorlí L, Montero M, Segura C, Durán X, Horcajada JP.

Rev Esp Quimioter. 2018 Apr;31(2):110-117. Epub 2018 Mar 9.

16.

Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain".

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02352-17. doi: 10.1128/AAC.02352-17. Print 2018 Jan. No abstract available.

17.

Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.

Molas E, Luque S, Retamero A, Echeverría-Esnal D, Guelar A, Montero M, Guerri R, Sorli L, Lerma E, Villar J, Knobel H.

HIV Clin Trials. 2018 Feb;19(1):1-7. doi: 10.1080/15284336.2017.1404690. Epub 2017 Nov 28.

PMID:
29179644
18.

Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.

Del Barrio-Tofiño E, López-Causapé C, Cabot G, Rivera A, Benito N, Segura C, Montero MM, Sorlí L, Tubau F, Gómez-Zorrilla S, Tormo N, Durá-Navarro R, Viedma E, Resino-Foz E, Fernández-Martínez M, González-Rico C, Alejo-Cancho I, Martínez JA, Labayru-Echverria C, Dueñas C, Ayestarán I, Zamorano L, Martinez-Martinez L, Horcajada JP, Oliver A.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01589-17. doi: 10.1128/AAC.01589-17. Print 2017 Nov. Erratum in: Antimicrob Agents Chemother. 2017 Dec 21;62(1):.

19.

High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections.

Herrera S, Sorlí L, Horcajada JP.

Med Clin (Barc). 2017 Sep 8;149(5):223-224. doi: 10.1016/j.medcli.2017.04.031. Epub 2017 Jun 8. English, Spanish. No abstract available.

PMID:
28602211
20.

Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.

Luque S, Escaño C, Sorli L, Li J, Campillo N, Horcajada JP, Salas E, Grau S.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e02595-16. doi: 10.1128/AAC.02595-16. Print 2017 Aug.

21.

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled trial.

Villar-García J, Güerri-Fernández R, Moya A, González A, Hernández JJ, Lerma E, Guelar A, Sorli L, Horcajada JP, Artacho A, D Auria G, Knobel H.

PLoS One. 2017 Apr 7;12(4):e0173802. doi: 10.1371/journal.pone.0173802. eCollection 2017.

22.

Ceftolozane-tazobactam for the treatment of ventilator-associated infections by colistin-resistant Pseudomonas aeruginosa.

Álvarez Lerma F, Muñoz Bermudez R, Grau S, Gracia Arnillas MP, Sorli L, Recasens L, Mico García M.

Rev Esp Quimioter. 2017 Jun;30(3):224-228. Epub 2017 Mar 29.

23.

C-reactive protein may misdiagnose prosthetic joint infections, particularly chronic and low-grade infections.

Pérez-Prieto D, Portillo ME, Puig-Verdié L, Alier A, Martínez S, Sorlí L, Horcajada JP, Monllau JC.

Int Orthop. 2017 Jul;41(7):1315-1319. doi: 10.1007/s00264-017-3430-5. Epub 2017 Mar 21.

PMID:
28321490
24.

Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.

Horcajada JP, Sorlí L, Luque S, Benito N, Segura C, Campillo N, Montero M, Esteve E, Mirelis B, Pomar V, Cuquet J, Martí C, Garro P, Grau S.

Int J Antimicrob Agents. 2016 Dec;48(6):725-727. doi: 10.1016/j.ijantimicag.2016.08.020. Epub 2016 Oct 7.

PMID:
28128096
25.

Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.

Sorlí L, Luque S, Segura C, Campillo N, Montero M, Esteve E, Herrera S, Benito N, Alvarez-Lerma F, Grau S, Horcajada JP.

BMC Infect Dis. 2017 Jan 5;17(1):11. doi: 10.1186/s12879-016-2117-7.

26.

Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection.

Lerma-Chippirraz E, Güerri-Fernández R, Villar García J, González Mena A, Guelar Grinberg A, Montero MM, Sorli L, Calzado S, Horcajada JP, Díez-Pérez A, Knobel Freud H.

AIDS Res Treat. 2016;2016:5120831. Epub 2016 Sep 6.

27.

Urinary micafungin levels are sufficient to treat urinary tract infections caused by Candida spp.

Grau S, Luque S, Echeverría-Esnal D, Sorlí L, Campillo N, Montero M, Álvarez Lerma F, Plasencia V, Horcajada JP.

Int J Antimicrob Agents. 2016 Aug;48(2):212-4. doi: 10.1016/j.ijantimicag.2016.05.010. Epub 2016 Jul 5.

PMID:
27424599
28.

Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study.

Benito N, Franco M, Ribera A, Soriano A, Rodriguez-Pardo D, Sorlí L, Fresco G, Fernández-Sampedro M, Dolores Del Toro M, Guío L, Sánchez-Rivas E, Bahamonde A, Riera M, Esteban J, Baraia-Etxaburu JM, Martínez-Alvarez J, Jover-Sáenz A, Dueñas C, Ramos A, Sobrino B, Euba G, Morata L, Pigrau C, Coll P, Mur I, Ariza J; REIPI (Spanish Network for Research in Infectious Disease) Group for the Study of Prosthetic Joint Infections.

Clin Microbiol Infect. 2016 Aug;22(8):732.e1-8. doi: 10.1016/j.cmi.2016.05.004. Epub 2016 May 13.

29.

Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection: the SEQUENCE cohort study.

Rodriguez-Pardo D, Pigrau C, Campany D, Diaz-Brito V, Morata L, de Diego IC, Sorlí L, Iftimie S, Pérez-Vidal R, García-Pardo G, Larrainzar-Coghen T, Almirante B.

Eur J Clin Microbiol Infect Dis. 2016 Aug;35(8):1269-76. doi: 10.1007/s10096-016-2661-5. Epub 2016 May 14.

30.

The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.

Herrera S, Guelar A, Sorlì L, Vila J, Molas E, Grau M, Marrugat J, Esteve E, Güerri-Fernández R, Montero M, Knobel H.

HIV Clin Trials. 2016 Jul;17(4):131-9. doi: 10.1080/15284336.2016.1177266. Epub 2016 May 12.

PMID:
27169692
31.

Characterization and rapid control of a vancomycin-resistant Enterococcus faecium (VREF) outbreak in a renal transplant unit in Spain: The environment matters.

Herrera S, Sorlí L, Pérez-Sáez MJ, Ruiz-Garbajosa P, Barrios C, Plasencia V, Montero M, Terradas R, Crespo M, Castells X, Cantón R, Pascual J, Horcajada JP.

Enferm Infecc Microbiol Clin. 2017 Jan;35(1):5-11. doi: 10.1016/j.eimc.2016.04.002. Epub 2016 May 5.

PMID:
27156245
32.

Enterococcal bloodstream infection. Design and validation of a mortality prediction rule.

Pérez-García A, Landecho MF, Beunza JJ, Conde-Estévez D, Horcajada JP, Grau S, Gea A, Mauleón E, Sorli L, Gómez J, Terradas R, Lucena JF, Alegre F, Huerta A, Del Pozo JL.

Int J Clin Pract. 2016 Feb;70(2):147-55. doi: 10.1111/ijcp.12754.

PMID:
26817569
33.

Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.

Esteve-Palau E, Solande G, Sánchez F, Sorlí L, Montero M, Güerri R, Villar J, Grau S, Horcajada JP.

J Infect. 2015 Dec;71(6):667-74. doi: 10.1016/j.jinf.2015.08.012. Epub 2015 Sep 14.

PMID:
26380898
34.

Clinical experience with the use of daptomycin in a tertiary care teaching hospital in Barcelona, Spain.

Sandoval N, Grau S, Sorlí L, Montero M, Esteve E, Horcajada JP.

Future Microbiol. 2015;10(7):1145-54. doi: 10.2217/fmb.15.41. Epub 2015 Jun 29.

PMID:
26119704
35.

Improved diagnosis of orthopedic implant-associated infection by inoculation of sonication fluid into blood culture bottles.

Portillo ME, Salvadó M, Trampuz A, Siverio A, Alier A, Sorli L, Martínez S, Pérez-Prieto D, Horcajada JP, Puig-Verdie L.

J Clin Microbiol. 2015 May;53(5):1622-7. doi: 10.1128/JCM.03683-14. Epub 2015 Mar 4.

36.

Effect of probiotics (Saccharomyces boulardii) on microbial translocation and inflammation in HIV-treated patients: a double-blind, randomized, placebo-controlled trial.

Villar-García J, Hernández JJ, Güerri-Fernández R, González A, Lerma E, Guelar A, Saenz D, Sorlí L, Montero M, Horcajada JP, Knobel Freud H.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):256-63. doi: 10.1097/QAI.0000000000000468.

PMID:
25469528
37.

Surfactant protein A genetic variants associate with severe respiratory insufficiency in pandemic influenza A virus infection.

Herrera-Ramos E, López-Rodríguez M, Ruíz-Hernández JJ, Horcajada JP, Borderías L, Lerma E, Blanquer J, Pérez-González MC, García-Laorden MI, Florido Y, Mas-Bosch V, Montero M, Ferrer JM, Sorlí L, Vilaplana C, Rajas O, Briones M, Aspa J, López-Granados E, Solé-Violán J, de Castro FR, Rodríguez-Gallego C.

Crit Care. 2014 Jun 20;18(3):R127. doi: 10.1186/cc13934.

38.

Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study.

Tornero E, Senneville E, Euba G, Petersdorf S, Rodriguez-Pardo D, Lakatos B, Ferrari MC, Pilares M, Bahamonde A, Trebse R, Benito N, Sorli L, del Toro MD, Baraiaetxaburu JM, Ramos A, Riera M, Jover-Sáenz A, Palomino J, Ariza J, Soriano A; European Society Group of Infections on Artificial Implants (ESGIAI).

Clin Microbiol Infect. 2014 Nov;20(11):1219-24. doi: 10.1111/1469-0691.12721.

39.

Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study.

Rodríguez-Pardo D, Pigrau C, Lora-Tamayo J, Soriano A, del Toro MD, Cobo J, Palomino J, Euba G, Riera M, Sánchez-Somolinos M, Benito N, Fernández-Sampedro M, Sorli L, Guio L, Iribarren JA, Baraia-Etxaburu JM, Ramos A, Bahamonde A, Flores-Sánchez X, Corona PS, Ariza J; REIPI Group for the Study of Prosthetic Infection.

Clin Microbiol Infect. 2014 Nov;20(11):O911-9. doi: 10.1111/1469-0691.12649. Epub 2014 Jun 14.

40.

[Pharmacokinetics and pharmacodynamics of ceftaroline].

Grau S, Sorlí L, Luque S.

Enferm Infecc Microbiol Clin. 2014 Mar;32 Suppl 2:15-20. doi: 10.1016/S0213-005X(14)70153-3. Review. Spanish.

PMID:
24702974
41.

Advantages of sonication fluid culture for the diagnosis of prosthetic joint infection.

Portillo ME, Salvadó M, Alier A, Martínez S, Sorli L, Horcajada JP, Puig L.

J Infect. 2014 Jul;69(1):35-41. doi: 10.1016/j.jinf.2014.03.002. Epub 2014 Mar 12.

PMID:
24631778
42.

Conventional and molecular diagnostic strategies for prosthetic joint infections.

Esteban J, Sorlí L, Alentorn-Geli E, Puig L, Horcajada JP.

Expert Rev Mol Diagn. 2014 Jan;14(1):83-96. doi: 10.1586/14737159.2014.861327. Epub 2013 Dec 6. Review.

PMID:
24308408
43.

Effective removal of colistin methanesulphonate and formed colistin during intermittent haemodialysis in a patient infected by polymyxin-only-susceptible Pseudomonas aeruginosa.

Luque S, Sorli L, Li J, Collado S, Barbosa F, Berenguer N, Horcajada JP, Grau S.

J Chemother. 2014 Apr;26(2):122-4. doi: 10.1179/1973947813Y.0000000104. Epub 2013 Dec 6.

PMID:
24090909
44.

Trough colistin plasma level is an independent risk factor for nephrotoxicity: a prospective observational cohort study.

Sorlí L, Luque S, Grau S, Berenguer N, Segura C, Montero MM, Alvarez-Lerma F, Knobel H, Benito N, Horcajada JP.

BMC Infect Dis. 2013 Aug 19;13:380. doi: 10.1186/1471-2334-13-380.

45.

Prosthesis failure within 2 years of implantation is highly predictive of infection.

Portillo ME, Salvadó M, Alier A, Sorli L, Martínez S, Horcajada JP, Puig L.

Clin Orthop Relat Res. 2013 Nov;471(11):3672-8. doi: 10.1007/s11999-013-3200-7. Epub 2013 Aug 1.

46.

Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.

Luque S, Grau S, Valle M, Sorlí L, Horcajada JP, Segura C, Alvarez-Lerma F.

Int J Antimicrob Agents. 2013 Aug;42(2):178-81. doi: 10.1016/j.ijantimicag.2013.04.018. Epub 2013 Jun 14.

PMID:
23769664
47.

Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain.

Rodríguez-Pardo D, Almirante B, Bartolomé RM, Pomar V, Mirelis B, Navarro F, Soriano A, Sorlí L, Martínez-Montauti J, Molins MT, Lung M, Vila J, Pahissa A; Barcelona Clostridium difficile Study Group.

J Clin Microbiol. 2013 May;51(5):1465-73. doi: 10.1128/JCM.03352-12. Epub 2013 Feb 27.

48.

Implant sonication increases the diagnostic accuracy of infection in patients with delayed, but not early, orthopaedic implant failure.

Puig-Verdié L, Alentorn-Geli E, González-Cuevas A, Sorlí L, Salvadó M, Alier A, Pelfort X, Portillo ME, Horcajada JP.

Bone Joint J. 2013 Feb;95-B(2):244-9. doi: 10.1302/0301-620X.95B2.30486.

PMID:
23365036
49.

Sonication versus vortexing of implants for diagnosis of prosthetic joint infection.

Portillo ME, Salvadó M, Trampuz A, Plasencia V, Rodriguez-Villasante M, Sorli L, Puig L, Horcajada JP.

J Clin Microbiol. 2013 Feb;51(2):591-4. doi: 10.1128/JCM.02482-12. Epub 2012 Nov 7.

50.

Multiplex PCR of sonication fluid accurately differentiates between prosthetic joint infection and aseptic failure.

Portillo ME, Salvadó M, Sorli L, Alier A, Martínez S, Trampuz A, Gómez J, Puig L, Horcajada JP.

J Infect. 2012 Dec;65(6):541-8. doi: 10.1016/j.jinf.2012.08.018. Epub 2012 Sep 4.

PMID:
22960370

Supplemental Content

Support Center